Starting Levothyroxine in a 60-kg Adult with Hypothyroidism
For a healthy 60-kg adult under 70 years without cardiac disease: start levothyroxine at 100 mcg daily (1.6 mcg/kg/day). 1, 2, 3
This full replacement dose is safe, reaches euthyroidism faster, and is more cost-effective than gradual titration in patients without cardiac risk factors. 4
Initial Dosing Algorithm
Standard Adult (Age <70, No Cardiac Disease, No Frailty)
- Start at full replacement dose: 1.6 mcg/kg/day 1, 2, 3
- For a 60-kg patient: 96 mcg daily (round to 100 mcg) 1, 3
- This approach is supported by a prospective randomized trial showing no cardiac events and faster achievement of euthyroidism compared to low-dose initiation 4
Elderly Patients (Age >70) OR Frail with Multiple Comorbidities
- Start at 25–50 mcg daily 1, 2, 3
- Titrate by 12.5–25 mcg every 6–8 weeks based on TSH 1, 2
- Lower starting doses prevent unmasking cardiac ischemia or precipitating arrhythmias in this vulnerable population 1, 2
Coronary Artery Disease (Any Age)
- Start at 25–50 mcg daily 1, 2, 3
- Titrate slowly by 12.5–25 mcg every 6–8 weeks 1, 2
- Even therapeutic doses of levothyroxine can unmask or worsen angina, precipitate myocardial infarction, or trigger arrhythmias in patients with underlying coronary disease 1
- Never start at full replacement dose in cardiac patients—this can cause myocardial infarction, heart failure, or fatal arrhythmias 1
Frail Patients (Regardless of Age)
- Start at 25–50 mcg daily 1, 2
- Titrate cautiously by 12.5 mcg increments every 6–8 weeks 1, 2
- Frailty increases risk of cardiac decompensation even at therapeutic doses 1
Monitoring and Dose Adjustment
Initial Monitoring
- Recheck TSH and free T4 every 6–8 weeks after any dose change 1, 2
- This interval allows levothyroxine to reach steady state 1, 2
- Free T4 helps interpret ongoing abnormal TSH levels, as TSH may take longer to normalize 1, 2
Dose Titration
- Adjust by 12.5–25 mcg increments every 6–8 weeks until TSH normalizes 1, 2
- Use smaller increments (12.5 mcg) in elderly or cardiac patients 1
- Use larger increments (25 mcg) in younger patients without cardiac disease 1
Target TSH
- Primary hypothyroidism: TSH 0.5–4.5 mIU/L with normal free T4 1, 5
- Aim for TSH between 1.0–3.0 mIU/L in young patients 5
- Accept upper normal range (closer to 4.5 mIU/L) in elderly or fragile patients 5
Long-Term Monitoring
Critical Pitfalls to Avoid
Do Not Start Full Dose in High-Risk Patients
- Starting at 1.6 mcg/kg/day in elderly, cardiac, or frail patients risks precipitating myocardial infarction, heart failure, or fatal arrhythmias 1, 2
Do Not Adjust Doses Too Frequently
- Wait 6–8 weeks between dose changes to allow steady state 1, 2
- Adjusting sooner leads to inappropriate dosing and potential overtreatment 1
Avoid Overtreatment
- Approximately 25% of patients on levothyroxine are unintentionally overtreated with suppressed TSH 1
- TSH <0.1 mIU/L increases risk of **atrial fibrillation (3–5 fold), osteoporosis, fractures, and cardiovascular mortality**, especially in patients >60 years 1
- If TSH falls below 0.1 mIU/L, reduce dose by 25–50 mcg immediately 1
- If TSH is 0.1–0.45 mIU/L, reduce by 12.5–25 mcg, particularly in elderly or cardiac patients 1
Rule Out Adrenal Insufficiency First
- In patients with suspected central hypothyroidism or hypophysitis, always start corticosteroids at least 1 week before levothyroxine 1, 2
- Starting thyroid hormone before adequate glucocorticoid coverage can precipitate life-threatening adrenal crisis 1, 2
Special Considerations
Pregnancy
- Levothyroxine requirements increase by 25–50% during pregnancy 1, 2, 3
- Check TSH every 6–8 weeks during pregnancy and adjust dose as needed 2, 3
- Target TSH <2.5 mIU/L in first trimester 1
Subclinical Hypothyroidism
- TSH >10 mIU/L: Start levothyroxine regardless of symptoms 1
- TSH 4.5–10 mIU/L: Routine treatment not recommended unless symptomatic, pregnant, or anti-TPO antibody positive 1, 2
Formulation Considerations
- Liquid or soft gel formulations may be considered in patients with malabsorption or who cannot wait 30–60 minutes before breakfast 1, 6
- These formulations are less affected by food and gastrointestinal conditions 6
Summary Table: Initial Levothyroxine Dosing
| Patient Population | Starting Dose | Titration Interval | Increment |
|---|---|---|---|
| Healthy adult <70 years, no cardiac disease | 1.6 mcg/kg/day (e.g., 100 mcg for 60 kg) [1,2,3] | 6–8 weeks [1,2] | 12.5–25 mcg [1,2] |
| Elderly (>70 years) | 25–50 mcg/day [1,2,3] | 6–8 weeks [1,2] | 12.5–25 mcg [1,2] |
| Coronary artery disease (any age) | 25–50 mcg/day [1,2,3] | 6–8 weeks [1,2] | 12.5 mcg [1] |
| Frail with multiple comorbidities | 25–50 mcg/day [1,2] | 6–8 weeks [1,2] | 12.5 mcg [1] |
The key principle: aggressive dosing in young, healthy patients; conservative dosing in elderly, cardiac, or frail patients. 1, 2, 3